PRESS RELEASE published on 09/09/2024 at 08:00, 2 months 12 days ago Informations privilégiées / Autres communiqués Ikonisys annonce le lancement de l'Ikoniscope Max en Europe lors du 36ème Congrès européen de pathologie à Florence. L'Ikoniscope Max offre une précision, une vitesse et une automatisation inégalées Lancement Ikonisys Florence Ikoniscope Max Pathologie
BRIEF published on 08/15/2024 at 07:05, 3 months 6 days ago Ikonisys réalise une augmentation de capital de 150 000 € Financement Placement Privé Augmentation De Capital Actions Nouvelles Ikonisys
BRIEF published on 08/15/2024 at 07:05, 3 months 6 days ago Ikonisys completes a capital increase of €150,000 Private Placement Funding Capital Increase New Actions Ikonisys
PRESS RELEASE published on 08/15/2024 at 07:00, 3 months 6 days ago Inside Information / Other news releases Ikonisys completes €150k capital increase via private placement to strengthen financial resources and support working capital needs, enhancing shareholder base and financial visibility Private Placement Capital Increase Financial Resources Shareholder Base Ikonisys
PRESS RELEASE published on 08/15/2024 at 07:00, 3 months 6 days ago Informations privilégiées / Autres communiqués Ikonisys finalise une augmentation de capital de 150 K€ par placement privé pour renforcer ses ressources en vue d'élargir sa base d'actionnaires et ses fonds de roulement Financements Placement Privé Augmentation De Capital Ikonisys Solutions Médicales
BRIEF published on 07/23/2024 at 10:11, 3 months 29 days ago Ikonisys SA Receives Buy Rating Despite Lower 2023 Figures Private Placement Financial Results 2023 Performance Sphene Capital Ikonisys
BRIEF published on 07/23/2024 at 10:11, 3 months 29 days ago Ikonisys SA reçoit une note d'achat malgré des chiffres inférieurs pour 2023 Résultats Financiers Placement Privé Performances 2023 Sphene Capital Ikonisys
PRESS RELEASE published on 07/23/2024 at 10:06, 3 months 29 days ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Sphene Capital GmbH updates research report on Ikonisys SA, adjusting price target to EUR 5.50 from EUR 6.30. Company's 2023 financial figures below expectations, 2024 forecasts driven by collaborations Financial Figures Ikonisys SA Price Target Collaborations Sphene Capital GmbH
BRIEF published on 07/18/2024 at 19:10, 4 months 2 days ago Ikonisys finalise une augmentation de capital de 250 000 € via un placement privé Placement Privé Augmentation De Capital Ressources Financières Détection Du Cancer Ikonisys
BRIEF published on 07/18/2024 at 19:10, 4 months 2 days ago Ikonisys Completes €250k Capital Increase Via Private Placement Private Placement Capital Increase Financial Resources Cancer Detection Ikonisys
Published on 11/21/2024 at 15:05, 34 minutes ago "The Not-So-Secret Lives of REAL 'Mormon' Wives" - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/21/2024 at 15:00, 39 minutes ago 2-10 Home Buyers Warranty Makes Triumphant Entry Into Oklahoma Market
Published on 11/21/2024 at 15:00, 39 minutes ago Sound Physicians’ ACO Achieves $22.9M Total Savings in 2023 Medicare Shared Savings Program
Published on 11/21/2024 at 15:00, 39 minutes ago BlackBerry AtHoc "In Process" Finalization for FedRAMP High Authorization
Published on 11/21/2024 at 15:00, 39 minutes ago RE Royalties Enters into Loan and Royalty Agreement with Abraxas Power for up to CAD $10 Million and Announces Loan Settlement with Switch Power
Published on 11/21/2024 at 15:24, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:22, 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 15:20, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Published on 11/21/2024 at 15:19, 19 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tritax EuroBox plc
Published on 11/21/2024 at 06:58, 8 hours 41 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 8 hours 41 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 8 hours 41 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 19 hours 32 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 20 hours 19 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
